Literature DB >> 9865524

Modifications of dopamine D1 receptor complex in rats self-administering cocaine.

M Graziella De Montis1, C Co, S I Dworkin, J E Smith.   

Abstract

Cocaine is spontaneously and experimentally self-administered and, when given repeatedly, it induces a stable form of sensitization to a previously assessed minimum active dose. In the present study, triads of rats chronically implanted with a jugular catheter were treated as follows: one animal was trained to self-inject cocaine, while the other two passively received either cocaine or saline whenever the self-administering rat completed the response requirement. After 30 days of stable responding, the animals were sacrificed and dopamine D1 receptor density and adenylyl cyclase activity were measured in different brain areas. Animals receiving cocaine (both self-administering and yoked) showed a down-regulation of dopamine D1 receptor number and of dopamine stimulated adenylyl cyclase activity in the nucleus accumbens, as compared to saline rats. In the olfactory tubercle, dopamine stimulated adenylyl cyclase activity appeared selectively and significantly down-regulated in self-administering animals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865524     DOI: 10.1016/s0014-2999(98)00731-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Changes in response to a dopamine receptor antagonist in rats with escalating cocaine intake.

Authors:  Serge H Ahmed; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2003-11-28       Impact factor: 4.530

2.  Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine.

Authors:  Osnat Ben-Shahar; Patrick Keeley; Mariana Cook; Wayne Brake; Megan Joyce; Myriel Nyffeler; Rebecca Heston; Aaron Ettenberg
Journal:  Brain Res       Date:  2006-12-11       Impact factor: 3.252

3.  Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration.

Authors:  K L Conrad; K Ford; M Marinelli; M E Wolf
Journal:  Neuroscience       Date:  2010-05-07       Impact factor: 3.590

4.  Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.

Authors:  Danielle L Graham; Regis Hoppenot; April Hendryx; David W Self
Journal:  Psychopharmacology (Berl)       Date:  2006-07-12       Impact factor: 4.530

5.  Diminished role of dopamine D1-receptor signaling with the development of an addicted phenotype in rats.

Authors:  Carolina P Ramôa; Susan E Doyle; Matthew D Lycas; Andrea K Chernau; Wendy J Lynch
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

Review 6.  The use of neuroproteomics in drug abuse research.

Authors:  Melinda E Lull; Willard M Freeman; Heather D VanGuilder; Kent E Vrana
Journal:  Drug Alcohol Depend       Date:  2009-11-17       Impact factor: 4.492

Review 7.  Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration.

Authors:  David W Self; Kwang-Ho Choi; Diana Simmons; John R Walker; Cynthia S Smagula
Journal:  Learn Mem       Date:  2004 Sep-Oct       Impact factor: 2.460

8.  Post-cocaine changes in regulator of G-protein signaling (RGS) proteins in the dorsal striatum: Relevance for cocaine-seeking and protein kinase C-mediated phosphorylation.

Authors:  Jenna Bilodeau; Marek Schwendt
Journal:  Synapse       Date:  2016-06-21       Impact factor: 2.562

9.  Role of adenosine receptor subtypes in methamphetamine reward and reinforcement.

Authors:  Kevin A Kavanagh; Drew C Schreiner; Sophia C Levis; Casey E O'Neill; Ryan K Bachtell
Journal:  Neuropharmacology       Date:  2014-10-06       Impact factor: 5.250

10.  Dopamine uptake changes associated with cocaine self-administration.

Authors:  Erik B Oleson; Sanjay Talluri; Steven R Childers; James E Smith; David C S Roberts; Keith D Bonin; Evgeny A Budygin
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.